articleThe Lancet OncologySep 12, 2007Closed access

Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial

University of Vermont · University of Pittsburgh · +11 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

1,078
total citations
FWCI
22.19
Percentile
100%
References
33
Citations per year

Authors

18

Topics & keywords

Keywords
  • Medicine
  • Axillary Lymph Node Dissection
  • Sentinel lymph node
  • Breast cancer
  • Surgery
  • Lymph node
  • Stage (stratigraphy)
  • Randomized controlled trial
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.